LiqTech International, Inc. is a clean technology firm that provides technologies for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company has market cap of $11.54 million. The Firm develops and makes products of re-crystallized silicon carbide. It currently has negative earnings. It specializes in two business areas, which include ceramic membranes for liquid filtration, and diesel particulate filters for the control of soot exhaust particles from diesel engines.
Front Barnett Associates Llc decreased Thermo Fisher Scientific Inc (TMO) stake by 2.76% reported in 2016Q4 SEC filing. Front Barnett Associates Llc sold 4,504 shares as Thermo Fisher Scientific Inc (TMO)’s stock rose 6.59%. The Front Barnett Associates Llc holds 158,705 shares with $22.39M value, down from 163,209 last quarter. Thermo Fisher Scientific Inc now has $59.40B valuation. The stock declined 0.31% or $0.47 reaching $152.42 per share. About 216,894 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 1.24% since September 6, 2016 and is uptrending. It has underperformed by 6.41% the S&P500.
Perkins Capital Management Inc holds 0.4% of its portfolio in LiqTech International Inc for 573,750 shares. Clear Harbor Asset Management Llc owns 2.13 million shares or 0.29% of their US portfolio. Moreover, Wealthtrust Axiom Llc has 0.16% invested in the company for 692,506 shares. The New York-based Selz Capital Llc has invested 0.04% in the stock. Parsons Capital Management Inc Ri, a Rhode Island-based fund reported 93,000 shares.
About 1,405 shares traded. LiqTech International Inc (NYSEMKT:LIQT) has declined 58.54% since September 6, 2016 and is downtrending. It has underperformed by 66.19% the S&P500.
Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on April, 27. They expect $2.03 EPS, up 12.78% or $0.23 from last year’s $1.8 per share. TMO’s profit will be $791.12M for 18.77 P/E if the $2.03 EPS becomes a reality. After $2.41 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -15.77% negative EPS growth.
Investors sentiment increased to 1.05 in Q4 2016. Its up 0.26, from 0.79 in 2016Q3. It is positive, as 52 investors sold TMO shares while 371 reduced holdings. 116 funds opened positions while 329 raised stakes. 330.70 million shares or 0.57% less from 332.58 million shares in 2016Q3 were reported. Envestnet Asset Inc holds 0.03% or 52,309 shares. State Of New Jersey Common Pension Fund D reported 85,000 shares. National Bank reported 5,235 shares. Mitchell Mcleod Pugh Williams invested 0.23% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Endurant Capital Management Ltd Partnership holds 2.13% or 36,486 shares. Moreover, Natixis Asset Management has 2.06% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Kingfisher Cap Limited Liability Corp holds 1.24% or 11,663 shares in its portfolio. Chilton Investment Lc has 3.13% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). 2,100 were reported by Nikko Asset Americas. Ariel Investments Ltd Liability Corp has invested 0.81% in Thermo Fisher Scientific Inc. (NYSE:TMO). Virginia-based Mngmt Of Virginia has invested 0.59% in Thermo Fisher Scientific Inc. (NYSE:TMO). Patten Grp accumulated 0% or 65 shares. 169,642 are owned by Polar Cap Ltd Liability Partnership. Checchi Capital Advisers Limited Company has invested 0.06% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Investec Asset Management North America accumulated 11,376 shares.
Since March 6, 2017, it had 0 buys, and 6 sales for $7.75 million activity. The insider Loewald Thomas W sold $642,617. Shares for $396,775 were sold by Williamson Stephen on Monday, March 6. On Wednesday, March 15 the insider CASPER MARC N sold $3.17M. $498,667 worth of stock was sold by HOOGASIAN SETH H on Monday, March 6. On Friday, March 10 the insider WILVER PETER M sold $1.58 million.
Among 14 analysts covering Thermo Fisher Scientific (NYSE:TMO), 12 have Buy rating, 0 Sell and 2 Hold. Therefore 86% are positive. Thermo Fisher Scientific has $180 highest and $140 lowest target. $157.79’s average target is 3.52% above currents $152.42 stock price. Thermo Fisher Scientific had 29 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, May 3 by Mizuho. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Overweight” rating given on Tuesday, July 19 by Barclays Capital. The firm has “Buy” rating by BTIG Research given on Friday, July 22. Mizuho maintained it with “Buy” rating and $170 target in Friday, May 27 report. Mizuho maintained the stock with “Buy” rating in Thursday, July 23 report. Stifel Nicolaus maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Monday, January 11. Stifel Nicolaus has “Buy” rating and $158 target. On Thursday, September 22 the stock rating was initiated by JP Morgan with “Overweight”. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Neutral” rating given on Friday, September 9 by Cleveland. The firm has “Buy” rating given on Thursday, January 7 by Deutsche Bank. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Argus Research on Tuesday, October 6.
